Global Tuberculosis Testing

Tuberculosis Testing Comprehensive Study by Type (TB skin test (TST), TB blood tests, Others), Application (Hospitals, Clinics, Others), Disease (Active Tuberculosis, Latent Tuberculosis) Players and Region - Global Market Outlook to 2026

Tuberculosis Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Tuberculosis Testing Market?

Tuberculosis is an infection caused by the bacteria Mycobacterium tuberculosis most often to the lungs. It can also be affecting the other parts of the body. Tuberculosis testing can be done by two methods including TB skin test (TST) and TB blood tests. These tests only tell that a person has been infected with TB bacteria. Other tests are needed to see if the person has latent TB infection or TB disease. According to the World Health Organization (WHO), In 2017, an estimated 4.4 million people fell ill with TB and an estimated 638,000 died because of the disease which is more than half of global TB deaths.

The market study is being classified by Type (TB skin test (TST), TB blood tests and Others), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up.

Abbott Laboratories (United States), Akonni Biosystems, Inc. (United States), Alere, Inc. (United States), Becton, Dickinson, and Company (United States), Cepheid (United States), Epistem Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (United States), bioMérieux SA (France) and Siemens Healthineers Inc. (Germany) are some of the key players profiled in the study.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Tuberculosis Testing market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Tuberculosis Testing market by Type, Application and Region.

On the basis of geography, the market of Tuberculosis Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Tuberculosis Infection among People
  • Increased Number of Diagnostic Centres and Hospitals
  • Government Initiatives about Tuberculosis Prevention

Market Trend
  • Demand for Advanced Tuberculosis Testing

Restraints
  • Lack of Healthcare Facility in Under Developed Countries

Opportunities
  • Growing Healthcare Industry Worldwide
  • Rising Awareness among People About Tuberculosis

Challenges
  • The need for Early Detection of the Tuberculosis Disease


Market Leaders and some development strategies




Key Target Audience
Tuberculosis Testing Providers, Research Companies, Emerging Companies and End-users

Report Objectives / Segmentation Covered

By Type
  • TB skin test (TST)
  • TB blood tests
  • Others
By Application
  • Hospitals
  • Clinics
  • Others
By Disease
  • Active Tuberculosis
  • Latent Tuberculosis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Tuberculosis Infection among People
      • 3.2.2. Increased Number of Diagnostic Centres and Hospitals
      • 3.2.3. Government Initiatives about Tuberculosis Prevention
    • 3.3. Market Challenges
      • 3.3.1. The need for Early Detection of the Tuberculosis Disease
    • 3.4. Market Trends
      • 3.4.1. Demand for Advanced Tuberculosis Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Tuberculosis Testing, by Type, Application, Disease and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Tuberculosis Testing (Value)
      • 5.2.1. Global Tuberculosis Testing by: Type (Value)
        • 5.2.1.1. TB skin test (TST)
        • 5.2.1.2. TB blood tests
        • 5.2.1.3. Others
      • 5.2.2. Global Tuberculosis Testing by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Tuberculosis Testing by: Disease (Value)
        • 5.2.3.1. Active Tuberculosis
        • 5.2.3.2. Latent Tuberculosis
      • 5.2.4. Global Tuberculosis Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Tuberculosis Testing (Volume)
      • 5.3.1. Global Tuberculosis Testing by: Type (Volume)
        • 5.3.1.1. TB skin test (TST)
        • 5.3.1.2. TB blood tests
        • 5.3.1.3. Others
      • 5.3.2. Global Tuberculosis Testing by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Tuberculosis Testing by: Disease (Volume)
        • 5.3.3.1. Active Tuberculosis
        • 5.3.3.2. Latent Tuberculosis
      • 5.3.4. Global Tuberculosis Testing Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Tuberculosis Testing (Price)
      • 5.4.1. Global Tuberculosis Testing by: Type (Price)
  • 6. Tuberculosis Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Akonni Biosystems, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alere, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson, and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cepheid (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Epistem Limited (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Thermo Fisher Scientific (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BioMérieux SA (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Siemens Healthineers Inc. (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Tuberculosis Testing Sale, by Type, Application, Disease and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Tuberculosis Testing (Value)
      • 7.2.1. Global Tuberculosis Testing by: Type (Value)
        • 7.2.1.1. TB skin test (TST)
        • 7.2.1.2. TB blood tests
        • 7.2.1.3. Others
      • 7.2.2. Global Tuberculosis Testing by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Tuberculosis Testing by: Disease (Value)
        • 7.2.3.1. Active Tuberculosis
        • 7.2.3.2. Latent Tuberculosis
      • 7.2.4. Global Tuberculosis Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Tuberculosis Testing (Volume)
      • 7.3.1. Global Tuberculosis Testing by: Type (Volume)
        • 7.3.1.1. TB skin test (TST)
        • 7.3.1.2. TB blood tests
        • 7.3.1.3. Others
      • 7.3.2. Global Tuberculosis Testing by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Tuberculosis Testing by: Disease (Volume)
        • 7.3.3.1. Active Tuberculosis
        • 7.3.3.2. Latent Tuberculosis
      • 7.3.4. Global Tuberculosis Testing Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Tuberculosis Testing (Price)
      • 7.4.1. Global Tuberculosis Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Tuberculosis Testing: by Type(USD Million)
  • Table 2. Tuberculosis Testing TB skin test (TST) , by Region USD Million (2015-2020)
  • Table 3. Tuberculosis Testing TB blood tests , by Region USD Million (2015-2020)
  • Table 4. Tuberculosis Testing Others , by Region USD Million (2015-2020)
  • Table 5. Tuberculosis Testing: by Application(USD Million)
  • Table 6. Tuberculosis Testing Hospitals , by Region USD Million (2015-2020)
  • Table 7. Tuberculosis Testing Clinics , by Region USD Million (2015-2020)
  • Table 8. Tuberculosis Testing Others , by Region USD Million (2015-2020)
  • Table 9. Tuberculosis Testing: by Disease(USD Million)
  • Table 10. Tuberculosis Testing Active Tuberculosis , by Region USD Million (2015-2020)
  • Table 11. Tuberculosis Testing Latent Tuberculosis , by Region USD Million (2015-2020)
  • Table 12. South America Tuberculosis Testing, by Country USD Million (2015-2020)
  • Table 13. South America Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 14. South America Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 15. South America Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 16. Brazil Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 17. Brazil Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 18. Brazil Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 19. Argentina Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 20. Argentina Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 21. Argentina Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 22. Rest of South America Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 25. Asia Pacific Tuberculosis Testing, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 29. China Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 30. China Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 31. China Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 32. Japan Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 33. Japan Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 34. Japan Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 35. India Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 36. India Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 37. India Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 38. South Korea Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 39. South Korea Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 40. South Korea Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 41. Taiwan Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 42. Taiwan Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 43. Taiwan Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 44. Australia Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 45. Australia Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 46. Australia Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 50. Europe Tuberculosis Testing, by Country USD Million (2015-2020)
  • Table 51. Europe Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 52. Europe Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 53. Europe Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 54. Germany Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 55. Germany Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 56. Germany Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 57. France Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 58. France Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 59. France Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 60. Italy Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 61. Italy Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 62. Italy Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 63. United Kingdom Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 66. Netherlands Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 67. Netherlands Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 68. Netherlands Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 69. Rest of Europe Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 72. MEA Tuberculosis Testing, by Country USD Million (2015-2020)
  • Table 73. MEA Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 74. MEA Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 75. MEA Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 76. Middle East Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 77. Middle East Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 78. Middle East Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 79. Africa Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 80. Africa Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 81. Africa Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 82. North America Tuberculosis Testing, by Country USD Million (2015-2020)
  • Table 83. North America Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 84. North America Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 85. North America Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 86. United States Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 87. United States Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 88. United States Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 89. Canada Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 90. Canada Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 91. Canada Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 92. Mexico Tuberculosis Testing, by Type USD Million (2015-2020)
  • Table 93. Mexico Tuberculosis Testing, by Application USD Million (2015-2020)
  • Table 94. Mexico Tuberculosis Testing, by Disease USD Million (2015-2020)
  • Table 95. Tuberculosis Testing Sales: by Type(K Units)
  • Table 96. Tuberculosis Testing Sales TB skin test (TST) , by Region K Units (2015-2020)
  • Table 97. Tuberculosis Testing Sales TB blood tests , by Region K Units (2015-2020)
  • Table 98. Tuberculosis Testing Sales Others , by Region K Units (2015-2020)
  • Table 99. Tuberculosis Testing Sales: by Application(K Units)
  • Table 100. Tuberculosis Testing Sales Hospitals , by Region K Units (2015-2020)
  • Table 101. Tuberculosis Testing Sales Clinics , by Region K Units (2015-2020)
  • Table 102. Tuberculosis Testing Sales Others , by Region K Units (2015-2020)
  • Table 103. Tuberculosis Testing Sales: by Disease(K Units)
  • Table 104. Tuberculosis Testing Sales Active Tuberculosis , by Region K Units (2015-2020)
  • Table 105. Tuberculosis Testing Sales Latent Tuberculosis , by Region K Units (2015-2020)
  • Table 106. South America Tuberculosis Testing Sales, by Country K Units (2015-2020)
  • Table 107. South America Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 108. South America Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 109. South America Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 110. Brazil Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 111. Brazil Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 112. Brazil Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 113. Argentina Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 114. Argentina Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 115. Argentina Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 116. Rest of South America Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 117. Rest of South America Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 118. Rest of South America Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 119. Asia Pacific Tuberculosis Testing Sales, by Country K Units (2015-2020)
  • Table 120. Asia Pacific Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 121. Asia Pacific Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 122. Asia Pacific Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 123. China Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 124. China Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 125. China Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 126. Japan Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 127. Japan Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 128. Japan Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 129. India Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 130. India Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 131. India Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 132. South Korea Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 133. South Korea Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 134. South Korea Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 135. Taiwan Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 136. Taiwan Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 137. Taiwan Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 138. Australia Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 139. Australia Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 140. Australia Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 141. Rest of Asia-Pacific Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 142. Rest of Asia-Pacific Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 144. Europe Tuberculosis Testing Sales, by Country K Units (2015-2020)
  • Table 145. Europe Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 146. Europe Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 147. Europe Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 148. Germany Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 149. Germany Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 150. Germany Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 151. France Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 152. France Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 153. France Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 154. Italy Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 155. Italy Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 156. Italy Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 157. United Kingdom Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 158. United Kingdom Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 159. United Kingdom Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 160. Netherlands Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 161. Netherlands Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 162. Netherlands Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 163. Rest of Europe Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 164. Rest of Europe Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 165. Rest of Europe Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 166. MEA Tuberculosis Testing Sales, by Country K Units (2015-2020)
  • Table 167. MEA Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 168. MEA Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 169. MEA Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 170. Middle East Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 171. Middle East Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 172. Middle East Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 173. Africa Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 174. Africa Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 175. Africa Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 176. North America Tuberculosis Testing Sales, by Country K Units (2015-2020)
  • Table 177. North America Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 178. North America Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 179. North America Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 180. United States Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 181. United States Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 182. United States Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 183. Canada Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 184. Canada Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 185. Canada Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 186. Mexico Tuberculosis Testing Sales, by Type K Units (2015-2020)
  • Table 187. Mexico Tuberculosis Testing Sales, by Application K Units (2015-2020)
  • Table 188. Mexico Tuberculosis Testing Sales, by Disease K Units (2015-2020)
  • Table 189. Tuberculosis Testing: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Tuberculosis Testing: by Type(USD Million)
  • Table 201. Tuberculosis Testing TB skin test (TST) , by Region USD Million (2021-2026)
  • Table 202. Tuberculosis Testing TB blood tests , by Region USD Million (2021-2026)
  • Table 203. Tuberculosis Testing Others , by Region USD Million (2021-2026)
  • Table 204. Tuberculosis Testing: by Application(USD Million)
  • Table 205. Tuberculosis Testing Hospitals , by Region USD Million (2021-2026)
  • Table 206. Tuberculosis Testing Clinics , by Region USD Million (2021-2026)
  • Table 207. Tuberculosis Testing Others , by Region USD Million (2021-2026)
  • Table 208. Tuberculosis Testing: by Disease(USD Million)
  • Table 209. Tuberculosis Testing Active Tuberculosis , by Region USD Million (2021-2026)
  • Table 210. Tuberculosis Testing Latent Tuberculosis , by Region USD Million (2021-2026)
  • Table 211. South America Tuberculosis Testing, by Country USD Million (2021-2026)
  • Table 212. South America Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 213. South America Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 214. South America Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 215. Brazil Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 216. Brazil Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 217. Brazil Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 218. Argentina Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 219. Argentina Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 220. Argentina Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 221. Rest of South America Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 222. Rest of South America Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 223. Rest of South America Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 224. Asia Pacific Tuberculosis Testing, by Country USD Million (2021-2026)
  • Table 225. Asia Pacific Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 226. Asia Pacific Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 227. Asia Pacific Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 228. China Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 229. China Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 230. China Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 231. Japan Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 232. Japan Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 233. Japan Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 234. India Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 235. India Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 236. India Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 237. South Korea Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 238. South Korea Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 239. South Korea Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 240. Taiwan Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 241. Taiwan Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 242. Taiwan Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 243. Australia Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 244. Australia Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 245. Australia Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 249. Europe Tuberculosis Testing, by Country USD Million (2021-2026)
  • Table 250. Europe Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 251. Europe Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 252. Europe Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 253. Germany Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 254. Germany Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 255. Germany Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 256. France Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 257. France Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 258. France Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 259. Italy Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 260. Italy Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 261. Italy Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 262. United Kingdom Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 263. United Kingdom Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 264. United Kingdom Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 265. Netherlands Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 266. Netherlands Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 267. Netherlands Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 268. Rest of Europe Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 269. Rest of Europe Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 270. Rest of Europe Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 271. MEA Tuberculosis Testing, by Country USD Million (2021-2026)
  • Table 272. MEA Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 273. MEA Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 274. MEA Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 275. Middle East Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 276. Middle East Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 277. Middle East Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 278. Africa Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 279. Africa Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 280. Africa Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 281. North America Tuberculosis Testing, by Country USD Million (2021-2026)
  • Table 282. North America Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 283. North America Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 284. North America Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 285. United States Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 286. United States Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 287. United States Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 288. Canada Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 289. Canada Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 290. Canada Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 291. Mexico Tuberculosis Testing, by Type USD Million (2021-2026)
  • Table 292. Mexico Tuberculosis Testing, by Application USD Million (2021-2026)
  • Table 293. Mexico Tuberculosis Testing, by Disease USD Million (2021-2026)
  • Table 294. Tuberculosis Testing Sales: by Type(K Units)
  • Table 295. Tuberculosis Testing Sales TB skin test (TST) , by Region K Units (2021-2026)
  • Table 296. Tuberculosis Testing Sales TB blood tests , by Region K Units (2021-2026)
  • Table 297. Tuberculosis Testing Sales Others , by Region K Units (2021-2026)
  • Table 298. Tuberculosis Testing Sales: by Application(K Units)
  • Table 299. Tuberculosis Testing Sales Hospitals , by Region K Units (2021-2026)
  • Table 300. Tuberculosis Testing Sales Clinics , by Region K Units (2021-2026)
  • Table 301. Tuberculosis Testing Sales Others , by Region K Units (2021-2026)
  • Table 302. Tuberculosis Testing Sales: by Disease(K Units)
  • Table 303. Tuberculosis Testing Sales Active Tuberculosis , by Region K Units (2021-2026)
  • Table 304. Tuberculosis Testing Sales Latent Tuberculosis , by Region K Units (2021-2026)
  • Table 305. South America Tuberculosis Testing Sales, by Country K Units (2021-2026)
  • Table 306. South America Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 307. South America Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 308. South America Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 309. Brazil Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 310. Brazil Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 311. Brazil Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 312. Argentina Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 313. Argentina Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 314. Argentina Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 315. Rest of South America Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 316. Rest of South America Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 317. Rest of South America Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 318. Asia Pacific Tuberculosis Testing Sales, by Country K Units (2021-2026)
  • Table 319. Asia Pacific Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 320. Asia Pacific Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 321. Asia Pacific Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 322. China Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 323. China Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 324. China Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 325. Japan Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 326. Japan Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 327. Japan Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 328. India Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 329. India Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 330. India Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 331. South Korea Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 332. South Korea Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 333. South Korea Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 334. Taiwan Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 335. Taiwan Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 336. Taiwan Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 337. Australia Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 338. Australia Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 339. Australia Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 340. Rest of Asia-Pacific Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 341. Rest of Asia-Pacific Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 342. Rest of Asia-Pacific Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 343. Europe Tuberculosis Testing Sales, by Country K Units (2021-2026)
  • Table 344. Europe Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 345. Europe Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 346. Europe Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 347. Germany Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 348. Germany Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 349. Germany Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 350. France Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 351. France Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 352. France Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 353. Italy Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 354. Italy Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 355. Italy Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 356. United Kingdom Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 357. United Kingdom Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 358. United Kingdom Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 359. Netherlands Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 360. Netherlands Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 361. Netherlands Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 362. Rest of Europe Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 363. Rest of Europe Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 364. Rest of Europe Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 365. MEA Tuberculosis Testing Sales, by Country K Units (2021-2026)
  • Table 366. MEA Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 367. MEA Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 368. MEA Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 369. Middle East Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 370. Middle East Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 371. Middle East Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 372. Africa Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 373. Africa Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 374. Africa Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 375. North America Tuberculosis Testing Sales, by Country K Units (2021-2026)
  • Table 376. North America Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 377. North America Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 378. North America Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 379. United States Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 380. United States Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 381. United States Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 382. Canada Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 383. Canada Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 384. Canada Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 385. Mexico Tuberculosis Testing Sales, by Type K Units (2021-2026)
  • Table 386. Mexico Tuberculosis Testing Sales, by Application K Units (2021-2026)
  • Table 387. Mexico Tuberculosis Testing Sales, by Disease K Units (2021-2026)
  • Table 388. Tuberculosis Testing: by Type(USD/Units)
  • Table 389. Research Programs/Design for This Report
  • Table 390. Key Data Information from Secondary Sources
  • Table 391. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Tuberculosis Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Tuberculosis Testing: by Application USD Million (2015-2020)
  • Figure 6. Global Tuberculosis Testing: by Disease USD Million (2015-2020)
  • Figure 7. South America Tuberculosis Testing Share (%), by Country
  • Figure 8. Asia Pacific Tuberculosis Testing Share (%), by Country
  • Figure 9. Europe Tuberculosis Testing Share (%), by Country
  • Figure 10. MEA Tuberculosis Testing Share (%), by Country
  • Figure 11. North America Tuberculosis Testing Share (%), by Country
  • Figure 12. Global Tuberculosis Testing: by Type K Units (2015-2020)
  • Figure 13. Global Tuberculosis Testing: by Application K Units (2015-2020)
  • Figure 14. Global Tuberculosis Testing: by Disease K Units (2015-2020)
  • Figure 15. South America Tuberculosis Testing Share (%), by Country
  • Figure 16. Asia Pacific Tuberculosis Testing Share (%), by Country
  • Figure 17. Europe Tuberculosis Testing Share (%), by Country
  • Figure 18. MEA Tuberculosis Testing Share (%), by Country
  • Figure 19. North America Tuberculosis Testing Share (%), by Country
  • Figure 20. Global Tuberculosis Testing: by Type USD/Units (2015-2020)
  • Figure 21. Global Tuberculosis Testing share by Players 2020 (%)
  • Figure 22. Global Tuberculosis Testing share by Players (Top 3) 2020(%)
  • Figure 23. Global Tuberculosis Testing share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 27. Akonni Biosystems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Akonni Biosystems, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Alere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Alere, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 33. Cepheid (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cepheid (United States) Revenue: by Geography 2020
  • Figure 35. Epistem Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Epistem Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 37. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2020
  • Figure 39. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 40. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 41. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 42. BioMérieux SA (France) Revenue: by Geography 2020
  • Figure 43. Siemens Healthineers Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Siemens Healthineers Inc. (Germany) Revenue: by Geography 2020
  • Figure 45. Global Tuberculosis Testing: by Type USD Million (2021-2026)
  • Figure 46. Global Tuberculosis Testing: by Application USD Million (2021-2026)
  • Figure 47. Global Tuberculosis Testing: by Disease USD Million (2021-2026)
  • Figure 48. South America Tuberculosis Testing Share (%), by Country
  • Figure 49. Asia Pacific Tuberculosis Testing Share (%), by Country
  • Figure 50. Europe Tuberculosis Testing Share (%), by Country
  • Figure 51. MEA Tuberculosis Testing Share (%), by Country
  • Figure 52. North America Tuberculosis Testing Share (%), by Country
  • Figure 53. Global Tuberculosis Testing: by Type K Units (2021-2026)
  • Figure 54. Global Tuberculosis Testing: by Application K Units (2021-2026)
  • Figure 55. Global Tuberculosis Testing: by Disease K Units (2021-2026)
  • Figure 56. South America Tuberculosis Testing Share (%), by Country
  • Figure 57. Asia Pacific Tuberculosis Testing Share (%), by Country
  • Figure 58. Europe Tuberculosis Testing Share (%), by Country
  • Figure 59. MEA Tuberculosis Testing Share (%), by Country
  • Figure 60. North America Tuberculosis Testing Share (%), by Country
  • Figure 61. Global Tuberculosis Testing: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Akonni Biosystems, Inc. (United States)
  • Alere, Inc. (United States)
  • Becton, Dickinson, and Company (United States)
  • Cepheid (United States)
  • Epistem Limited (United Kingdom)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Thermo Fisher Scientific (United States)
  • bioMérieux SA (France)
  • Siemens Healthineers Inc. (Germany)
Select User Access Type

Key Highlights of Report


Nov 2021 212 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Tuberculosis Testing Quantitative research analysis
Global Tuberculosis Testing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Tuberculosis Infection among People " is seen as one of major growth factors of Tuberculosis Testing Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Tuberculosis Testing Market in coming years.

Know More About Global Tuberculosis Testing Report?

Have a Query? Click Here

Other Related Reports

Human Papilloma Virus Testing Comprehensive Study by Type (Pap Smear Test, HPV DNA Test), Application (Diagnostic Centers, Hospitals, Clinic), Product Types (Consumables, Systems), Valence (Bivalent,...
$ 3650
IoT Healthcare Comprehensive Study by Application (Telemedicine, Work Flow Management, Connected Imaging, Medication Management), By Component (System and Software, Medical Devices, Services), By End...
$ 3650
Outbound Medical Tourism Services Comprehensive Study by Application (Adult, Children), Service Provider (Public, Private), Service (Medical VISA, Appointment Fixation, Treatment/Check-up Packages, C...
$ 3800
Leukapheresis Comprehensive Study by Type (Leukapheresis Disposables, Leukapheresis Devices (Apheresis Devices, Leukapheresis Columns & Cell Separators and Other)), Application (Research Institute, T...
$ 3750
Liver Function Tests Comprehensive Study by Type (Alanine Aminotransferase Test, Aspartate Aminotransferase Test, Alkaline Phosphatase Test, Gamma GT Test, Total Bilirubin, Albumin, Others), Applicat...
$ 3650
Male Infertility Treatment Comprehensive Study by Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm P...
$ 3800